SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-24-004203
Filing Date
2024-08-01
Accepted
2024-08-01 21:18:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11436197_13g-a.htm SC 13G/A 129205
  Complete submission text file 0000919574-24-004203.txt   130771
Mailing Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 212-848-0519
SAMLYN CAPITAL, LLC (Filed by) CIK: 0001421097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Subject) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89443 | Film No.: 241168598
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)